Abstract
ObjectiveAssess long-term safety, tolerability and efficacy of bimekizumab in ankylosing spondylitis (radiographic axial spondyloarthritis (r-axSpA)).MethodsPatients with active r-axSpA completing the dose-ranging 48-week randomised controlled trial could enrol in the open-label...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have